Alcobra relentlessly pursues creative, unbeaten paths for the identification, development and commercialization of therapeutics for impairing CNS disorders

We are committed to developing safe and effective products for the treatment of cognitive disorders including
ADHD and Fragile X Syndrome.

NEW  Alcobra Ltd. and Arcturus Therapeutics, Inc. Agree to Merge

View Press release

Arcturus Merger w/Alcobra Conference Call - Listen to webcast